ACUTAAS CHEMICALS LIMITED
Fundamental Score
ACUTAAS CHEMICALS LIMITED Share Price Live NSE/BSE
Profitability Metrics
Return on Equity
Return on Capital Employed
Operating Profit Margin (5Y)
Dividend Yield
Valuation Metrics
Price to Earnings
Market Capitalization
Industry P/E
Growth Metrics
YoY Quarterly Profit Growth
YoY Quarterly Sales Growth
Sales Growth (5Y)
EPS Growth (5Y)
Profit Growth (5Y)
Financial Health
Debt to Equity
Interest Coverage
Free Cash Flow (5Y)
Ownership Structure
Promoter Holding
FII Holding
DII Holding
Pledged Percentage
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Market Data Analysis & Educational Insights
Educational evaluation of ACUTAAS across key market metrics for learning purposes.
Positive Indicators
11 factors identified
Strong Return on Equity (16.00%)
Observation: Efficient use of shareholders' capital generating superior returns.
Analysis: ROE >15% indicates strong profitability and effective management. This metric suggests the company can generate substantial returns on invested capital.
Excellent ROCE Performance (19.92%)
Observation: Superior returns on capital employed across business operations.
Analysis: ROCE >15% demonstrates efficient capital deployment and strong operational performance. This indicates quality business fundamentals.
Strong Operating Margins (20.91%)
Observation: Healthy 5-year operating margins indicate pricing power and cost control.
Analysis: OPM >15% suggests operational efficiency and competitive advantages. This indicates sustainable profitability potential.
Robust Profit Growth (93.52%)
Observation: Strong year-over-year profit expansion demonstrates business momentum.
Analysis: Profit growth >20% indicates effective execution and market opportunity capture. This suggests positive business trajectory.
Strong Revenue Growth (24.10%)
Observation: Healthy sales growth indicates market demand and execution capability.
Analysis: Revenue growth >15% suggests strong market position and growth potential. This indicates business expansion success.
Consistent Growth Track Record (33.26% CAGR)
Observation: Strong 5-year sales compound annual growth rate.
Analysis: Consistent sales CAGR >12% demonstrates sustainable growth model and market opportunity execution over time.
Strong Profit Growth Track Record (41.40% CAGR)
Observation: Consistent 5-year profit compound annual growth rate.
Analysis: Profit CAGR >15% demonstrates scalable business model and effective operational leverage over time.
Conservative Debt Levels (D/E: 0.01)
Observation: Low leverage provides financial flexibility and reduced risk.
Analysis: Conservative debt structure offers resilience during economic downturns and flexibility for growth investments.
Strong Interest Coverage (120.69x)
Observation: Earnings comfortably cover interest obligations.
Analysis: Interest coverage >5x indicates low financial distress risk and strong debt servicing capability.
Strong Institutional Confidence (FII+DII: 39.43%)
Observation: Significant professional investor participation indicates quality recognition.
Analysis: High institutional holding often signals thorough due diligence and quality business fundamentals.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral, reducing forced-selling risk.
Analysis: Absence of share pledging eliminates potential forced-selling pressure during market stress.
Risk Factors
4 factors identified
Premium Valuation Risk (P/E: 64.86x)
Observation: High valuation multiples may limit upside potential.
Analysis: Elevated P/E ratios require strong growth execution to justify current valuations. Consider entry timing carefully.
Negative Free Cash Flow (₹-418.98 Cr over 5Y)
Observation: Cash outflows exceed inflows, indicating capital intensity or working capital issues.
Analysis: Negative FCF requires analysis of capital expenditure cycle and working capital management efficiency.
High P/E Ratio
Observation: Stock may be overvalued relative to earnings.
Analysis: P/E above 30 requires strong growth execution to justify current valuations.
Very High P/E Ratio
Observation: Significant overvaluation risk present.
Analysis: Extremely high P/E ratios indicate potential bubble territory and high downside risk.
Financial Statements
Comprehensive financial data for ACUTAAS CHEMICALS LIMITED
About ACUTAAS
Business Overview
Acutaas Chemicals Limited engages in the research and development, manufacture, and sale of pharmaceutical intermediates in India and internationally. The company offers pharma intermediates for use in regulated and generic active pharmaceutical ingredients for anti-retroviral, anti-inflammatory, anti-psychotic, anti-cancer, anti-Parkinson's, antidepressant, and anticoagulant applications. It also provides specialty chemicals for use in battery chemicals, personal care, agrochemicals, coatings, electronics, and industrial processes; photoresist chemicals to semiconductor applications; electrolyte additives for lithium battery cells; and parabens, methyl salicylate, and other commodity chemicals for cosmetics, agrochemicals, and fine chemicals. The company was formerly known as Ami Organics Limited and changed its name to Acutaas Chemicals Limited in May 2025. Acutaas Chemicals Limited was founded in 2004 and is based in Surat, India.
Company Details
Key Leadership
Corporate Events
ACUTAAS Stock Details & Analysis
Key Financial Metrics
Growth & Valuation
Frequently Asked Questions
What is the current price of ACUTAAS CHEMICALS LIMITED (ACUTAAS)?
As of 30 Jan 2026, 01:35 pm IST, ACUTAAS CHEMICALS LIMITED (ACUTAAS) is currently trading at ₹1912.50. The stock has a market capitalization of ₹14.53K (Cr).
Is ACUTAAS share price Overvalued or Undervalued?
ACUTAAS is currently trading at a P/E ratio of 64.86x, compared to the industry average of 31.77x. Based on this relative valuation, the stock appears to be Overvalued against its sector peers.
What factors affect the ACUTAAS CHEMICALS LIMITED share price?
Key factors influencing ACUTAAS's price include its quarterly earnings growth (Sales Growth: 24.10%), raw material costs, government infrastructure spending, and institutional flows (FII/DII holding).
Is ACUTAAS CHEMICALS LIMITED a good stock for long-term investment?
ACUTAAS CHEMICALS LIMITED shows a 5-year Profit Growth of 41.40% and an ROE of 16.00%. Long-term investors should consider these fundamentals alongside the debt-to-equity ratio of 0.01 before investing.
How does ACUTAAS CHEMICALS LIMITED compare with its industry peers?
ACUTAAS CHEMICALS LIMITED competes with major peers in the Pharmaceuticals. Investors should compare ACUTAAS's P/E of 64.86x and ROE of 16.00% against the industry averages to determine its competitive standing.
What is the P/E ratio of ACUTAAS and what does it mean?
ACUTAAS has a P/E ratio of 64.86x compared to the industry average of 31.77x. The Price-to-Earnings (P/E) ratio is calculated by dividing the current share price by earnings per share (EPS). This means investors are paying ₹65 for every ₹1 of annual earnings.
How is ACUTAAS performing according to Bull Run's analysis?
ACUTAAS has a Bull Run fundamental score of 64.1/100, which indicates moderate strength with some areas for improvement. This comprehensive rating is based on 15+ financial parameters including profitability, growth metrics, and valuation ratios.
What sector and industry does ACUTAAS belong to?
ACUTAAS operates in the Pharmaceuticals industry. This classification helps understand the competitive landscape and sector-specific trends affecting ACUTAAS CHEMICALS LIMITED.
What is Return on Equity (ROE) and why is it important for ACUTAAS?
ACUTAAS has an ROE of 16.00%, which indicates excellent management efficiency and profitable operations. Return on Equity measures how efficiently ACUTAAS CHEMICALS LIMITED generates profits from shareholders' equity.
How is ACUTAAS's debt-to-equity ratio and what does it indicate?
ACUTAAS has a debt-to-equity ratio of 0.01, which indicates conservative financing with low financial risk. A ratio below 1.0 generally indicates conservative financing.
What is ACUTAAS's dividend yield and is it a good dividend stock?
ACUTAAS offers a dividend yield of 0.08%, which means you receive ₹0.08 annual dividend for every ₹100 invested.
How has ACUTAAS grown over the past 5 years?
ACUTAAS has achieved 5-year growth rates of: Sales Growth 33.26%, Profit Growth 41.40%, and EPS Growth 7.70%.
What is the promoter holding in ACUTAAS and why does it matter?
Promoters hold 32.66% of ACUTAAS shares, with 0.00% of promoter shares pledged. High promoter holding often indicates strong management confidence.
What is ACUTAAS's market capitalization category?
ACUTAAS has a market capitalization of ₹14526 crores, placing it in the Mid-cap category.
How volatile is ACUTAAS stock?
ACUTAAS has a beta of N/A. A beta > 1 suggests the stock is more volatile than the market, while a beta < 1 suggests it is less volatile.
What is the 52-week high and low for ACUTAAS?
ACUTAAS has a 52-week high of ₹N/A and low of ₹N/A.
What is ACUTAAS's operating profit margin trend?
ACUTAAS has a 5-year average Operating Profit Margin (OPM) of 20.91%, indicating the company's operational efficiency.
How is ACUTAAS's quarterly performance?
Recent quarterly performance shows YoY Sales Growth of 24.10% and YoY Profit Growth of 93.52%.
What is the institutional holding pattern in ACUTAAS?
ACUTAAS has FII holding of 16.84% and DII holding of 22.59%. Significant institutional holding often suggests professional confidence in the stock.